Full cycle of development and production of pharmaceutical products and dietary supplements
Clinical studies
and systematic analysis of scientific publications. Support for the certification process required to include information about the efficacy and beneficial properties of dietary supplements on their packaging.
Our strengths
End-to-end brand launch
from idea to mass production
From 5000
units per batch
GMP, ISО
compliance with Russian and international standards
«Chestny znak»
release with national product labeling system
Clinical studies
we collaborate with leading medical centers
Delivery
operations across Russia and the CIS
Why choose us?
We are constantly seeking new ways to improve patients' quality of life. Our success is built on scientific innovations, which we actively integrate into the production processes of our products
More about us
Full transparency
24/7 video monitoring of the production process
In-house R&D center
PhD-level staff
Full-cycle services
From formulation development to documentation for entry into Russian and international markets
Professional team
Key technical and production personnel with 15+ years of industry experience
Quality control
Batch-by-batch quality control of manufactured products
About us
For over 20 years, we have successfully balanced contract manufacturing with our own product development
Partners about us
Frequently asked questions
Contract manufacturing involves producing items under your brand at our manufacturing facility. We can manage the entire project on a turnkey basis, or step in at any specific stage—whether that means developing a formula, selecting a product format, preparing documentation, or handling the technology transfer to move the production process to our facilities.
We can create an analogue of a product available on the market for you (a complete analogue in terms of components, or an alternative composition with the same effect). We can develop a complementary dietary supplement to complement your cosmetic line or in line with the logic of your service.
The minimum order quantity is 5,000 units of the product.
The timeframe for launching a new product is individual and largely depends on the complexity of the project, the specifics of the raw materials, and the order volume.
When we begin our partnership, we will coordinate the schedules for planned shipments with you and incorporate your product into our production plan in advance. If establishing an annual shipment calendar is difficult, we recommend submitting new orders 2–3 months prior to the desired shipment date; this ensures that the manufacturing of your product is integrated into our production queue and allows sufficient time for the necessary quality control procedures.
As soon as the necessary final inspection is completed and the quality documentation is prepared, we will be ready to ship the ordered products to you. Delivery terms are discussed on an individual basis and specified in the contract.
Every project is unique, so we can only provide estimated timelines.
Launching a new dietary supplement brand on the market is quite quick. If the product is selected from our list of ready‑made and registered formulations, the customer only needs to approve the design and place an order for packaging materials. Such orders are completed within 2–3 months.
If a new composition is planned, its scientific and technological development will be required, as well as the state registration procedure. Such projects are usually implemented within a period of up to 6 months.
Запуск нового лекарственного препарата займет намного больше времени, нежели БАД. От появления идеи нового препарата до вывода его на рынок может пройти 5 - 10 лет: полная фармразработка формулы, доклинические исследования для проверки гипотезы и подтверждения механизма действия; затем - клинические исследования I и II фазы с участием добровольцев для всесторонней оценки безопасности и эффективности. Только после этого возможна регистрация лекарственного средства, которая сопровождается обязательным подтверждением контроля качества производственного процесса.
Launching a generic drug is simpler and faster, potentially taking about a year and a half. Since the pharmaceutical development phase and in-depth research have already been completed for the original drug, a generic version does not require extensive clinical or preclinical studies. Typically, a bioequivalence study is sufficient; in other words, it is necessary to demonstrate that the formulation matches that of the original (reference) drug.
Contact us
News
We attended the 27th Pharmacy Summit